Health In Tech, Inc. Class A Common Stock (HIT) is a publicly traded Technology sector company. As of May 21, 2026, HIT trades at $0.97 with a market cap of $68.81M and a P/E ratio of -50.95. HIT moved +2.97% today. Year to date, HIT is -40.24%; over the trailing twelve months it is +54.22%. Its 52-week range spans $0.51 to $7.59. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces HIT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Health In Tech Q1 Revenue Rises 9.4% to $8.8M, Guides $45M–$50M for 2026: Health In Tech's Q1 2026 revenue rose 9.4% to $8.8 million, but adjusted EBITDA swung to a $1.3 million loss and net loss reached $1.6 million, or $0.03 per share. It retains 2026 revenue guidance of $45m–$50m on $22.9m in contracted revenue and a 29.5% rise in distribution partners to 896.
| Metric | Value |
|---|---|
| Price | $0.97 |
| Market Cap | $68.81M |
| P/E Ratio | -50.95 |
| EPS | $-0.02 |
| Dividend Yield | 0.38% |
| 52-Week High | $7.59 |
| 52-Week Low | $0.51 |
| Volume | 724 |
| Avg Volume | 0 |
| Revenue (TTM) | $34.08M |
| Net Income | $-808.03K |
| Gross Margin | 58.95% |
2 analysts cover HIT: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.